Table of Contents
1 Industry Outlook 8
1.1 Industry Overview 8
1.2 Industry Trends 9
2 Report Outline 10
2.1 Report Scope 10
2.2 Report Summary 10
2.3 Research Methodology 11
2.4 Report Assumptions 12
3 Market Snapshot 13
3.1 Total Addressable Market 13
3.2 Market Definition - Infoholic Research 13
3.3 Segmented Addressable Market 13
3.4 Trends in Wound Care Biologics Market 14
3.5 Related Markets 15
3.5.1 Active Pharmaceutical Ingredients 15
3.5.2 Diabetes Drugs 16
3.5.3 Regenerative Medicine 16
3.5.4 Oncology (Cancer) Drugs 17
4 Market Outlook 18
4.1 Regulatory Outlook 18
4.2 Market Segmentation 19
4.3 Porter 5(Five) Forces 19
4.4 PEST Analysis 20
5 Market Characteristics 21
5.1 Market Dynamics 21
5.1.1 Drivers 22
5.1.1.1 Increasing aging population 22
5.1.1.2 Rising incidence of chronic wounds 22
5.1.1.3 Increasing number of people suffering from diabetes 23
5.1.1.4 Increasing acceptance of innovative technologies for complex wound treatment 23
5.1.2 Opportunities 24
5.1.2.1 Increase in healthcare spending 24
5.1.2.2 Untapped emerging market in developing countries 24
5.1.3 Restraints 24
5.1.3.1 Complex regulatory process 24
5.1.3.2 High cost of biologic wound care 25
5.2 DRO - Impact Analysis 26
5.3 Key Stakeholders 27
6 Types: Market Size and Analysis 28
6.1 Overview 28
6.2 Growth Factors 29
6.3 Skin Substitutes 30
6.4 Enzyme-based Products 33
7 Application: Market Size and Analysis 35
7.1 Overview 35
7.2 Chronic Wound 36
7.3 Acute Wound 36
8 End-users: Market Size and Analysis 37
8.1 Overview 37
8.2 Hospitals & Clinics 37
8.3 Ambulatory Surgical Centers 38
9 Regions: Market Size and Analysis 39
9.1 Overview 39
9.2 North America 40
9.2.1 Overview 40
9.2.2 US 41
9.2.3 Canada 42
9.3 Europe 42
9.3.1 Overview 42
9.3.2 UK 44
9.3.3 Germany 44
9.4 Asia Pacific 44
9.4.1 Overview 44
9.4.2 India 45
9.4.3 China 45
9.5 Rest of the World 46
9.5.1 Overview 46
9.5.2 Middle East & Africa 47
9.5.3 Brazil 47
10 Competitive Landscape 49
11 Vendor Profiles 51
11.1 Smith & Nephew' Inc. 51
11.1.1 Overview 51
11.1.2 Geographic Revenue 54
11.1.3 Business Focus 54
11.1.4 SWOT Analysis 55
11.1.5 Business Strategies 55
11.2 Organogenesis Inc. 56
11.2.1 Overview 56
11.2.2 Business Focus 57
11.2.3 SWOT Analysis 57
11.2.4 Business Strategies 58
11.3 MiMedx 58
11.3.1 Overview 58
11.3.2 Business Focus 59
11.3.3 SWOT Analysis 60
11.3.4 Business Strategies 60
11.4 Integra Life Sciences Corp. 61
11.4.1 Overview 61
11.4.2 Geographic Revenue 63
11.4.3 Business Focus 64
11.4.4 SWOT Analysis 64
11.4.5 Business Strategies 65
12 Companies to Watch For 66
12.1 Pinnacle Transplant Technologies 66
12.1.1 Overview 66
12.2 Osiris Therapeutics' Inc. 66
12.2.1 Overview 66
12.2.2 Highlights 67
12.3 Molnlycke Health Care AB 67
12.3.1 Overview 67
12.4 Soluble Systems' LLC 68
12.4.1 Overview 68
12.4.2 Highlights 68
12.5 Applied Biologics 69
12.5.1 Overview 69
12.6 Skye Biologics 69
12.6.1 Overview 69
Annexure 71
Abbreviations 71